• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

EU Files WTO Case Against China Over IP Rights Protection

06/06/2018 by William New, Intellectual Property Watch 2 Comments

The European Union has filed a World Trade Organization dispute settlement complaint against China for unfair treatment of foreign intellectual property rights holders. The case follows a similar filing by the United States against China.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, IP Law, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WTO/TRIPS

EUIPO Study Looks At State Of IPR Infringement In The EU

06/06/2018 by Monika Ermert for Intellectual Property Watch Leave a Comment

A report published today by the EU Intellectual Property Office (EUIPO) deplores rising volume of intellectual property rights infringement in both immaterial goods and digital content and warns against the economic effects for the Union.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, Enforcement, English, Europe, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

Experts In Geneva: Substandard, Falsified Medicines Not About IP

06/06/2018 by Catherine Saez, Intellectual Property Watch 1 Comment

Falsified and substandard medical products continue to be a global concern, and how those products are characterised is important to avoid confusion, particularly with intellectual property rights infringement. A panel convened by Brazil, India and South Africa yesterday at the World Trade Organization looked at the implications of a new definition of such products at the neighbouring World Health Organization.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Enforcement, English, Health & IP, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WHO, WTO/TRIPS

Terminando con el acceso no autorizado a los recursos genéticos (biopiratería): Apertura delimitada

06/06/2018 by Intellectual Property Watch 1 Comment

El “acceso a los recursos genéticos” y “la participación justa y equitativa de los beneficios que provienen de su utilización” han atribulado las trece Conferencias de las Partes del Convenio de las Naciones Unidas sobre la Diversidad Biológica(CDB), que entró en vigor en 1993. La expresión entre comillas se conoce por sus siglas en inglés como “ABS”. Es el tercer objetivo del Convenio, entrelazado con los primeros dos, que son la conservación y el uso sostenible. A pesar de 25 años de esfuerzos y una bioeconomía de casi un trillón de dólares, pocos son los contratos de acceso que han sido celebrados. De esos pocos, los beneficios monetarios son tan bajos que las partes contratantes (y otros actores) son reacias a divulgarlos, bajo la excusa de “confidencialidad por sensibilidades comerciales”. La ley brasileña de ABS de 2015, que entró en vigor el 6 de noviembre de 2017 por ejemplo, permite que las regalías de las ventas netas sean tan bajas como la décima parte de uno por ciento. En palabras de un erudito jurista, los Usuarios pagan “una miseria por la biodiversidad”.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Biodiversity/Genetic Resources/Biotech, Enforcement, English, Environment, Human Rights, Patents/Designs/Trade Secrets, UPOV / CBD, United Nations - other

European Patent Office Discusses Patenting Artificial Intelligence

01/06/2018 by Monika Ermert for Intellectual Property Watch 1 Comment

MUNICH — United States and Chinese patent practitioners this week called for considerations to change patent legislation and allow patenting algorithms in the future. They spoke at a 30 May conference of the European Patent Office in Munich on “Patenting Artificial Intelligence.”

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, English, Europe, Innovation/ R&D, New Technologies, Patents/Designs/Trade Secrets, Regional Policy

New South African IP Policy Text Now Available

31/05/2018 by Intellectual Property Watch Leave a Comment

The new Intellectual Property Policy of South Africa has now been posted to a government website.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Africa, Enforcement, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

‘Every Great Science Discovery, Invention, Is The Stuff Of Dreams, Not The Stuff Of Reason’: Interview With David Hanson Of Hanson Robotics

29/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

Sophia, the well-known human-like robot who acquired citizenship in Saudi Arabia, was at the Artificial Intelligence for Good Global Summit which took place earlier this month in Geneva. Her creator, David Hanson, also CEO and founder of Hanson Robotics, gave an interview to Intellectual Property Watch’s Catherine Saez and explained his philosophy about intellectual property, the needed spark of interest in human-like robots, data collection, and innovation.

Hanson is also lead designer and inventor of key technologies including Frubber nanotech, facial expressions and AI software. He is former Walt Disney Imagineering designer, and recipient of numerous awards. A video interview about Sophia is embedded in this text.

Filed Under: Features, IP Policies, Subscribers, Themes, Venues, Copyright Policy, English, Innovation/ R&D, New Technologies, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains, United Nations - other

IP Rights Through Two Lenses At Next Week’s TRIPS Council: Improving Lives, Competition Law

29/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

Next week, the World Trade Organization intellectual property committee is invited to discuss two distinct aspects of intellectual property protection. One group of countries is proposing to explore the value of IP and its role in improving lives in a persistent agenda item on IP and innovation. Another group of countries is pushing for a more recent agenda on IP and the public interest and next week is suggesting to discuss how to use competition laws against the abuse of IP rights.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Copyright Policy, English, Finance, Innovation/ R&D, New Technologies, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

Fake Medicines To Be Discussed On Side Of WTO TRIPS Council Next Week

29/05/2018 by Intellectual Property Watch Leave a Comment

Alongside next week’s World Trade Organization intellectual property committee meeting, Brazil, India, and South Africa are convening a workshop on the neighbouring World Health Organization’s approach to substandard and falsified medicines.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WHO, WTO/TRIPS

MPP Board Gives Green Light To Expansion, Now Has To Identify Candidates

28/05/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment

The Medicines Patent Pool announced this week that its Board agreed on the extension of the MPP mandate to patented medicines on the World Health Organization Essential Medicines List. The decision follows an extensive feasibility study. During a side event held on the margins of the annual World Health Assembly, Patent Pool officials explained the findings of the study, while in the audience, a representative of the pharmaceutical industry suggested a cautious approach.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, Development, English, Finance, Health & IP, Innovation/ R&D, Other International Orgs, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHA 2018, WHO

  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 442
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting